(4S)-4-(3-[18F]fluoropropyl-)-L-glutamate
Showing 1 - 25 of >10,000
Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior Trial in Nashville (procedure, radiation, drug, other)
Completed
- Lung Carcinoma
- +2 more
- Computed Tomography
- +5 more
-
Nashville, Tennessee
- +1 more
Oct 17, 2022
Cigarette Smoker, Current Smoker, Former Smoker Trial in Palo Alto (Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18
Recruiting
- Cigarette Smoker
- +4 more
- Computed Tomography
- +3 more
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Jun 16, 2022
18F-FSPG PET/CT Imaging in Patients With Cancers
Recruiting
- Pulmonary Cancer
- +2 more
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 29, 2019
Solid Malignancy, Lymphoma Trial in New York ([18F] 4-L-Fluoroglutamine (2S,4R))
Recruiting
- Solid Malignancy
- Lymphoma
- [18F] 4-L-Fluoroglutamine (2S,4R)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 28, 2022
Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)
Not yet recruiting
- Marginal Zone Lymphoma
- (no location specified)
Nov 6, 2023
Glioblastoma Trial in Rochester (radiation, procedure, drug, other)
Recruiting
- Glioblastoma
- Accelerated Hypofractionated Radiation Therapy
- +8 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 24, 2023
Breast Cancer, Breast Tumor Trial in Philadelphia ([18F]ISO-1)
Active, not recruiting
- Breast Cancer
- Breast Neoplasm
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Jan 17, 2023
An Imaging Agent With Positron Emission Tomography/Magnetic
Recruiting
- Recurrent Soft Tissue Sarcoma
- +2 more
- Fluorodopa F 18
- +4 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 4, 2023
Radiotracer, Hypertension, Cholesterol Trial in Ann Arbor (Dexamethasone (Group 2), Cosyntropin (Group 3), PET/CT Scan with
Recruiting
- Radiotracer
- +2 more
- Dexamethasone (Group 2)
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan
Dec 9, 2022
Tobacco Use Disorder, Tobacco Smoking Trial in Baltimore ([F18]-ASEM
Recruiting
- Tobacco Use Disorder
- Tobacco Smoking
- [F18]-ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-[18F]fluorodibenzo[b,d]thiophene 5,5-dioxide)
- Contingency Management
-
Baltimore, MarylandJohns Hopkins Behavioral Pharmacology Research Unit
Jun 7, 2022
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Nashville (procedure, drug, other, biological, radiation)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +9 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 11, 2022
Primary Knee Osteoarthritis Grade 3 - 4 Trial in Tbilisi (Lipocet® (food supplement), Lipocet Placebo)
Completed
- Primary Knee Osteoarthritis Grade 3 - 4
- Lipocet® (food supplement)
- Lipocet Placebo
-
Tbilisi, Georgia
- +2 more
Nov 10, 2023
Prostate Cancer, Prostate Cancer Metastatic, Prostatic Tumor Trial in Vancouver (18F-DCFPyL PET/CT scan, Placebo drink, MSG
Completed
- Prostate Cancer
- +2 more
- 18F-DCFPyL PET/CT scan
- +2 more
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 15, 2021
Mild Cognitive Impairment Trial in Philadelphia (2-(2-([18F]fluoro)pyridin-4-yl)-9H-pyrrolo[2,3-b:4,5-c']dipyridine)
Recruiting
- Mild Cognitive Impairment
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, School of Medicine
Dec 9, 2022
Hyperinsulinism Trial in Saint Louis (18F-Fluoro Dopa PET/MRI Imaging)
Recruiting
- Hyperinsulinism
- 18F-Fluoro Dopa PET/MRI Imaging
-
Saint Louis, MissouriWashington University
Oct 8, 2021
Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4), Stage IIb Breast Cancer (T3N0) Trial in Canada (Whole-body FDG PET-CT
Active, not recruiting
- Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4)
- Stage IIb Breast Cancer (T3N0)
- Whole-body FDG PET-CT alone
-
Hamilton, Ontario, Canada
- +5 more
Apr 19, 2022
Sarcoma Trial in Toronto (18F-FAZA, Pimonidazole)
Recruiting
- Sarcoma
-
Toronto, Ontario, CanadaUniversity Health Network
Apr 11, 2022
Malignant Glioma Trial in Rochester (procedure, drug, radiation, other)
Active, not recruiting
- Malignant Glioma
- Diffusion Weighted Imaging
- +6 more
-
Rochester, MinnesotaMayo Clinic
Jul 15, 2022
Oral Upadacitinib Tablets to Assess Change in Disease Symptoms
Recruiting
- Rheumatoid Arthritis (RA)
-
Edmonton, Alberta, Canada
- +38 more
Jan 17, 2023
Brodalumab in Plaque Psoriasis to Understand Impact on Quality
Recruiting
- Psoriasis
- Brodalumab
- Matched cohort
-
Calgary, Alberta, Canada
- +33 more
Oct 8, 2022
Influenza Trial in Toronto, Mirabel, Pointe-Claire (H1 influenza antigen)
Completed
- Influenza
- H1 influenza antigen
-
Toronto, Ontario, Canada
- +2 more
Nov 3, 2023
Alzheimer Trial in Canada, United States (18F-Flortaucipir radiopharmaceutical, 18F-MK-6240 radiopharmaceutical, Amyloid-ß
Recruiting
- Alzheimer Disease
- 18F-Flortaucipir radiopharmaceutical
- +2 more
-
Berkeley, California
- +7 more
Jan 23, 2023
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Graft Rejection, Heart Transplantation, Liver Transplantation Trial in Seoul ([18F]FSPG)
Recruiting
- Graft Rejection
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 15, 2022
Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)
Not yet recruiting
- Localized Osteosarcoma
- +3 more
- Cabozantinib S-malate
- +7 more
- (no location specified)
Jan 4, 2023